Zhou zu Bang

Dr. Zhou zu Bang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2023 in Frontiers in Oncology
Verified
Journal Article
Open access
WMWenrong Mu
Wenrong Mu
ZBZhou zu Bang
Zhou zu Bang
LSLiping Shao
Liping Shao
QWQi Wang
Qi Wang
WFWanxue Feng
Wanxue Feng
YWYuanlin Wang
Yuanlin Wang
Epithelial-mesenchymal transition (EMT) is a cellular reprogramming process that converts epithelial cells into mesenchymal-like cells with migratory and invasive capabilities. The initiation and regulation of EMT is closely linked to a range of transcription factors, cell adhesion molecules and signaling pathways, which play a key role in cancer metastasis and drug resistance. The regulation of ferroptosis is intricately linked to various cell death pathways, intracellular iron homeostasis, and the protein network governing iron supply and storage. The ability of ferroptosis to disrupt cancer cells and overcome drug resistance lies in its control of intracellular iron ion levels. EMT process can promote the accumulation of iron ions, providing conditions for ferroptosis. Conversely, ferroptosis may impact the regulatory network of EMT by modulating transcription factors, signaling pathways, and cell adhesion molecules. Thus, ferroptosis related genes and signaling pathways and oxidative homeostasis play important roles in the regulation of EMT. In this paper, we review the role of ferroptosis related genes and their signaling pathways in regulating cancer EMT to better understand the crosstalk mechanism between ferroptosis and EMT, aiming to provide better therapeutic strategies for eradicating cancer cells and overcoming drug resistance.

9 January 2022 in International Journal of Hyperthermia
Verified
Journal Article
Open access
ZBZhou zu Bang
Zhou zu Bang
YXYa-E Xue
Ya-E Xue
YYYan-Wu Yao
Yan-Wu Yao
XZXue-Ting Zhang
Xue-Ting Zhang
MZMing-Hua Zhang
Ming-Hua Zhang
JXJin-Hui Xie
Jin-Hui Xie
This study aimed to determine the performance of Sonazoid-based contrast-enhanced ultrasound (CEUS) in the microwave ablation (MWA) of primary hyperparathyroidism (pHPT).Forty patients with pHPT we...

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
RLRuoxuan Li
Ruoxuan Li
JHJiping Hao
Jiping Hao
ZZZhao Zhu
Zhao Zhu
XQXudong Qiao
Xudong Qiao
LWLing Wang
Ling Wang
ZBZhou zu Bang
Zhou zu Bang
The aim of this study was to explore the correlation between ultrasound‐guided fine‐needle aspiration cytology(US‐FNAC) combined with BRAF V600E mutation analysis and central neck lymph node metastasis in cN0 papillary thyroid cancer, so as to provide reliable molecular evidence to use it for preoperative evaluation, operation procedure design, and postoperative follow‐up planning in clinic. Specimens were obtained from 250 patients with cN0 thyroid cancer (TI‐RADS≥4a, highly suspected of PTC by US‐FNAC) after bilateral thyroidectomy and central neck lymph node dissection with accessible postoperative pathologic results of PTC and central neck lymph nodes and used for cytological diagnosis by H&E stain and BRAF V600E mutation detection. Single‐factor analysis showed that differences between the central neck lymph node metastasis and nonmetastasis groups were statistically significant in gender, BRAF V600E mutation, and extracapsular extension. Logistic multivariate regression analysis showed significant differences in gender, BRAF V600E mutation, and extracapsular extension. Positive BRAF V600E mutations by US‐FNAC, extracapsular extension, and male gender are risk factors of central neck lymph node metastasis in cN0 PTC metastatic PTC to central neck lymph node. Patients with those factors should undergo prophylactic central neck lymph node dissection.

1 May 2025 in Radiology: Artificial Intelligence
Verified
Journal Article
Closed access
CCChen Chen
Chen Chen
JYJiabin Yu
Jiabin Yu
ZXZhikang Xu
Zhikang Xu
CXChangsong Xu
Changsong Xu
ZBZhou zu Bang
Zhou zu Bang
DXDong Xu
Dong Xu
The pseudo–contrast-enhanced US (CEUS) method, based on enhanced generative adversarial networks, demonstrated high similarity to real CEUS in evaluating tumor ablation effectiveness.

17 February 2023 in Frontiers in Surgery
Verified
Journal Article
Open access
YLYushan Li
Yushan Li
MYMaodong Ye
Maodong Ye
BJBaolong Jia
Baolong Jia
LCLinwei Chen
Linwei Chen
ZBZhou zu Bang
Zhou zu Bang
Objective: This study aims to assess the effectiveness of the Gradient Boosting (GB) algorithm on glioma prognosis prediction and to explore new predictive models for glioma patient survival after tumor resection.Methods: A cohort of 776 glioma cases (WHO grades II–IV) between 2010 and 2017 was obtained. Clinical characteristics and biomarker information were reviewed. Subsequently, we constructed the conventional Cox survival model and three different supervised machine learning models, including support vector machine (SVM), random survival forest (RSF), Tree GB, and Component GB. Then, the model performance was compared with each other. At last, we also assessed the feature importance of models.Results: The concordance indexes of the conventional survival model, SVM, RSF, Tree GB, and Component GB were 0.755, 0.787, 0.830, 0.837, and 0.840, respectively. All areas under the cumulative receiver operating characteristic curve of both GB models were above 0.800 at different survival times. Their calibration curves showed good calibration of survival prediction. Meanwhile, the analysis of feature importance revealed Karnofsky performance status, age, tumor subtype, extent of resection, and so on as crucial predictive factors.Conclusion: Gradient Boosting models performed better in predicting glioma patient survival after tumor resection than other models.

10 September 2025 in International Journal of Surgery
Verified
Journal Article
Open access
JZJianhua Zhou
Jianhua Zhou
LLLingling Li
Lingling Li
KYKun Yan
Kun Yan
Yuanyi ZhengYuanyi Zheng
Yuanyi Zheng
TJTian’an Jiang
Tian’an Jiang
PLPing Liang
Ping Liang
Sonazoid, a combined blood pool and Kupffer-cell agent, can be specifically phagocytosed by Kupffer cells in the liver, allowing lesion detection and characterization of focal liver lesions (FLLs) at the post-vascular phase, apart from the vascular phase, which is similar to that of other second-generation ultasound (US) contrast agents. Sonazoid contrast-enhanced US (CEUS) is currently approved for use in some Asian countries. With the increasing use of Sonazoid CEUS for FLLs in clinical practice, developing consensus or guidelines to help standardize its use is required. The expert consensus aimed to review recent evidence and make evidence-based recommendations for radiologists and clinicians involved in the management of liver diseases regarding the use of Sonazoid CEUS in the surveillance or detection, characterization of FLLs, CEUS for interventional and intraoperative use, and tumor treatment response evaluation in patients with FLLs. This consensus was conducted without using artificial intelligence tools in accordance with the TITAN Guidelines 2025.